Interoception, broadly understood as the sensing of internal bodily states, encompasses multiple dimensions, each reflecting a different aspect of how we perceive, evaluate, and regulate signals from within. This new study carefully categorizes interoception into four validated dimensions: accuracy, sensibility, awareness, and a cognitive–emotional evaluation dimension termed ‘Other.’ By dissecting these components, researchers aim to untangle which facets of interoception bear the strongest associations with self-harming behaviors and suicidal ideation.

One of the most striking findings concerns interoceptive accuracy—the ability to correctly detect internal bodily signals, such as heartbeats or respiratory rhythms. Contrary to what might be expected, the analysis reveals only weak, non-significant links between accuracy and both self-harm and suicidal outcomes. This challenges simplistic assumptions that merely perceiving bodily signals with high precision might directly influence severe emotional distress or dangerous behavioral expressions.

In contrast, the dimension termed interoceptive sensibility emerges as a key player. This aspect captures individuals’ self-reported tendencies and trust in bodily sensations, as well as their ability to use those sensations for self-regulation during distress. The meta-analysis exposes generally negative associations between interoceptive sensibility and suicidal ideation, plans, and attempts. Specifically, greater trust in bodily signals and more effective self-regulation correlated with lower levels of suicidal behavior, underscoring the protective potential embedded in mindful bodily awareness.

Though data on interoceptive awareness were insufficient to include in a quantitative meta-analysis, the broader literature hints at its importance. Awareness involves an individual’s conscious recognition and integration of their internal state, a nuanced process that likely intersects with emotional regulation and cognitive appraisal, both critical in suicide risk. Future research targeting this dimension could yield deeper insights or unearth therapeutic pathways.

The ‘Other’ category, representing the cognitive–emotional evaluation of bodily signals, also reveals compelling connections. Deficits in how individuals interpret the significance or emotional meaning of bodily cues were positively associated with both non-suicidal self-injury (NSSI) and suicidal ideation. These findings suggest that disruptions not only in sensing but also in the interpretative and evaluative processing of internal signals may heighten vulnerability to self-harm.

Impressively, the review extends beyond behavioral correlations to explore the neural underpinnings that might be driving these associations. Neuroimaging studies implicated alterations in core interoceptive processing regions—the insula and prefrontal cortex. These brain areas orchestrate emotional awareness, decision-making, and adaptive regulation, all of which are impaired in individuals at risk of suicide. The convergence of interoceptive deficits and neural dysfunction in these zones hints at shared substrates for bodily self-awareness and suicidal behavior, although current evidence remains preliminary and exploratory.

The study’s comprehensive approach addresses a longstanding need to transcend fragmented and qualitative observations about interoception’s role in suicidality. By meta-analytically quantifying effect sizes across distinct interoceptive dimensions and suicidal outcomes, the research provides a clearer map for subsequent investigation. It challenges researchers and clinicians alike to consider not just emotional or cognitive risk factors but also foundational sensory processes that influence how distress is experienced and managed.

Beyond expanding the theoretical understanding of suicide risk, these findings hold promising clinical implications. Targeting interoceptive sensibility and cognitive–emotional evaluation through therapeutic interventions might equip individuals with enhanced capacities for bodily trust and regulation, potentially mitigating self-harm and suicidal tendencies. Approaches such as mindfulness-based therapies, biofeedback, and body-oriented psychotherapy are well-positioned to build upon these insights.

The scarcity of longitudinal and intervention studies identified in the review also signals the urgency for future research to establish causality and treatment efficacy. While most included studies were cross-sectional, prospective analyses could elucidate how changes in interoceptive processing either precede or follow episodes of self-harm or suicidal ideation, refining temporal models of risk.

This study marks a critical step toward integrating interoception into the broader psychopathological landscape. It invites an interdisciplinary dialogue spanning psychology, neuroscience, psychiatry, and behavioral medicine, encouraging exploration of how the body’s internal signals interface with mental states and behaviors that culminate in self-injury.

Ultimately, this meta-analysis does more than synthesize existing knowledge—it recalibrates our understanding of the embodied mind. By illuminating the nuanced role of interoception in self-harm and suicide, it opens promising avenues for innovation in both research methodology and clinical practice, holding the potential to save countless lives through more informed recognition and treatment of internal sensory processing.

As suicide remains one of the most urgent global health challenges, integrating bodily awareness into risk assessment models and therapeutic frameworks is not merely academic—it is a profound human imperative. The integration of interoceptive science into mental health paradigms could redefine prevention strategies and revolutionize interventions aimed at those silently battling internal turmoil.

Future exploration will undoubtedly delve deeper into specific neural circuits, developmental trajectories, and intervention mechanisms, striving to translate these foundational insights into tangible improvements in patient care. The interplay between mind and body is complex and intimate, and this study serves as a clarion call to embrace this complexity in seeking solutions to some of the most agonizing expressions of human suffering.

In this challenging frontier, interoception emerges not only as a scientific concept but as a vital key to understanding the lifecycle of distress that can culminate in self-harm and suicidal action—underscoring how deeply our sense of self is tied to the often overlooked whispers of our own physiology.

Subject of Research: Interoception and its relationship to self-harm and suicidal behavior

Article Title: Interoception in self-harm and suicide: a scoping review and meta-analysis

Article References:
Liu, B., Wu, Z., Xue, M. et al. Interoception in self-harm and suicide: a scoping review and meta-analysis. Nat Hum Behav (2026). https://doi.org/10.1038/s41562-026-02490-9

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41562-026-02490-9

Suicide remains a leading cause of death worldwide, representing a major public health challenge. Conventional suicide-risk assessment tools traditionally do not differentiate between the risk factors for suicide attempts and those that precipitate suicide completion. This study, however, employed rigorous case-control methodologies to parse out subtle yet significant differences in the profiles of individuals prone to attempting suicide versus those who ultimately die by suicide. Such distinctions may open new avenues for tailored interventions and preventative strategies that are more precise and effective.

The research team, led by Fenfen Ge, MD, PhD, from Aarhus University, utilized extensive clinical and epidemiological data sets to examine various psychological, behavioral, and biological contributors to suicide risk. By comparing cases of suicide attempts with completed suicides and matched control groups, the investigators identified distinct patterns of vulnerability. These patterns illuminate how certain risk factors may predispose individuals to suicidal ideation and attempts, while a different constellation of factors might influence the transition to completed suicide.

One of the most compelling findings is that the overlap between suicide attempt risk factors and those predicting suicide death is incomplete, underscoring the complexity of suicidal behavior. For example, factors such as impulsivity and acute stress responses were more strongly correlated with attempts, whereas chronic psychiatric conditions and severe neurobiological dysregulation showed stronger ties to completed suicides. This suggests that a one-size-fits-all approach to suicide risk assessment could miss critical warning signs depending on the suicidal trajectory.

From a neurobiological standpoint, the study highlights distinct mechanisms operating in the brain’s stress response and reward processing systems. Dysregulation in these systems may differentially modulate risk propensities toward attempts versus completion, reflecting nuanced neural circuit dysfunctions. Such mechanistic insights are vital for developing pharmacological and behavioral therapies that target precise pathways involved in suicidal behavior.

In addition to biological factors, psychosocial elements were rigorously evaluated. The investigation revealed that social isolation, access to lethal means, and past trauma played variable roles in mediating risk for suicide attempt compared with suicide completion. The role of protective factors such as social support networks was also dissected, indicating differential buffering effects depending on the suicidal outcome examined, thereby informing community and clinical interventions.

Clinically, these findings pave the way for refined screening tools that can better stratify patients according to their unique risk profiles. The ability to distinguish whether a patient is more likely to attempt suicide or progress toward completion could guide personalized care plans, including the intensity and type of monitoring, therapeutic approaches, and follow-up schedules. It also underscores the importance of ongoing risk reassessment in diverse clinical contexts.

Moreover, the study emphasizes the imperative to integrate genetic and epigenetic data into risk prediction models. By identifying genetic susceptibilities that differentially influence suicide attempt and completion risk, the research invites a new era of precision psychiatry where genomic information will complement clinical and psychosocial assessments to optimize prevention strategies.

The author team calls for future research to validate these findings across broader demographic groups and geographical regions, including longitudinal studies that can elucidate the temporal dynamics of risk evolution. Furthermore, they advocate for interdisciplinary approaches that combine psychiatry, genetics, neurobiology, and social sciences, fostering comprehensive frameworks to address the multifactorial nature of suicide.

This research not only advances scientific understanding but also carries significant ethical and policy implications. It urges stakeholders in health care systems, mental health services, and public health policy to rethink suicide prevention protocols, resource allocation, and training programs for clinicians. Enhanced awareness about the heterogeneity of suicide risk could reduce stigma by framing suicidality as a complex, multifaceted phenomenon require nuanced interventions.

In summary, this pivotal study disrupts traditional paradigms by demonstrating that suicide attempts and completed suicides are governed by overlapping yet distinct risk factors. The results compel a paradigm shift toward differentiated risk prediction and personalized preventive measures. As global suicide rates reflect the urgent need for improved intervention, these findings offer promising scientific pathways to save lives.

Fenfen Ge, MD, PhD, the study’s corresponding author, encourages colleagues and media representatives to delve deeper into the full publication accessible via JAMA Psychiatry for an exhaustive exposition of the methodologies, analyses, and clinical implications. Harnessing these insights to develop next-generation suicide prevention strategies is an urgent imperative for modern psychiatry.

Subject of Research: Suicide risk factors differentiating suicide attempt and suicide completion

Article Title: [Not Provided]

News Publication Date: [Not Provided]

Web References: [Not Provided]

References: (10.1001/jamapsychiatry.2025.3444)

Image Credits: [Not Provided]

Keywords: Suicide, Risk factors, Controlled trials, Patient monitoring, Psychiatry

First-episode psychosis represents a critical juncture in the trajectory of severe mental disorders, often marking the onset of a lifelong struggle with schizophrenia spectrum illnesses and bipolar disorder. Yet, it is during this initial phase that patients are most vulnerable and simultaneously most amenable to treatment. The review underscores this paradox, delineating how the early psychotic phase encapsulates a high-risk window not only for worsening psychopathology but also for emergent behaviors like cannabis consumption and suicidal ideation or attempts. Understanding the delicate interplay between psychosis onset and these risk factors is pivotal for tailoring preventive interventions that could reshape patient futures.

Cannabis use emerges from the review as a particularly vexing factor, both as a potential trigger and an exacerbating element during the earliest stages of psychosis. Neurologically, cannabinoids interact with the endocannabinoid system, modulating neurotransmission in areas crucial for emotional regulation and cognitive function. For individuals entering the psychotic spectrum, this modulation may heighten susceptibility to psychotic exacerbations or intensify symptom severity. Moreover, cannabis use often co-occurs during high-risk periods, muddying clinical pictures and complicating treatment adherence. The review meticulously charts these temporal relationships, revealing how cannabis consumption can act as a catalyst, worsening prognosis and elevating suicide risk.

Suicide risk within the psychosis spectrum remains alarmingly high, especially in the early phases of illness. The narrative review presents compelling data on suicide ideation spikes and attempts, emphasizing that these tragic outcomes frequently manifest soon after psychosis onset, particularly in conjunction with substance use like cannabis. This confluence of factors creates a volatile psychological landscape, where despair, impaired reality testing, and impulsivity converge perilously. By illuminating these patterns, the review advocates for proactive suicide risk assessments and integrated substance use interventions during critical treatment windows.

A sophisticated component of the review involves the identification of “opportunity windows”—periods when clinical interventions might interrupt negative trajectories. These windows are not static but fluctuate along illness progression, patient engagement, and environmental factors. Early intervention teams focusing on first-episode psychosis have capitalized on these windows through psychoeducation, pharmacotherapy, cognitive behavioral therapy, and family support. The review adds nuance by mapping when cannabis-related behaviors might be most modifiable, indicating moments for targeted harm reduction strategies. Recognition of these timing factors could revolutionize service delivery models, shifting care from reactive crisis management to preemptive, nuanced intervention.

From a neurodevelopmental perspective, the authors explore how adolescent and early adulthood stages critically underpin vulnerability to psychosis and substance use. Brain maturation processes, including synaptic pruning and myelination, occur concurrently with exposure to environmental stressors and cannabis use, potentially precipitating psychotic episodes. The review synthesizes emerging neuroimaging studies that reveal altered connectivity patterns in reward and executive control networks among patients with combined psychosis and cannabis use histories. This mechanistic insight strengthens the argument for age- and developmentally tailored prevention initiatives, underscoring the necessity of early cannabis use screening in at-risk youth populations.

The narrative systematic review also attends to the heterogeneity across patient presentations, highlighting that not every individual experiences the same risk escalation or response to cannabis exposure. Genetic predispositions, social determinants, and comorbid psychiatric disorders create a complex mosaic influencing vulnerability and resilience. Precision psychiatry approaches, utilizing biomarkers and longitudinal profiling, may help stratify patients according to their risk windows, tailoring interventions with unprecedented specificity. The authors envisage a future where integrative clinical frameworks consider these multifactorial elements for personalized care pathways.

In addition to individual-level factors, the review illuminates broader social and environmental contexts shaping risk patterns. Socioeconomic adversity, stigma related to psychosis and substance use, and precarious access to health services act as systemic barriers that prolong untreated psychosis duration and compound suicide risk. The researchers emphasize how marginalized populations often encounter delays in diagnosis and care, constricting critical opportunity windows for intervention. Addressing these inequities through policy reforms and community outreach emerges as a crucial agenda to complement clinical advances.

Critically, the review integrates findings from longitudinal cohort studies that track patients from first-episode psychosis onset through various illness phases. Such data reveal how initial cannabis use trajectories often predict subsequent clinical outcomes, including hospitalization rates, symptom remission, and suicidal behaviors. These longitudinal insights are essential for constructing predictive models that can inform early warning systems within mental health settings. Healthcare systems equipped with such predictive capabilities could allocate resources more efficiently, focusing intensive interventions on those at highest imminent risk.

Within the pharmacological arena, the review discusses current evidence regarding antipsychotic medications’ effects on suicide risk and cannabis use patterns. While medications remain the cornerstone of psychosis management, emerging concerns about side effects, adherence difficulties, and their interplay with substance use complicate clinical decisions. Notably, some antipsychotics may mitigate impulsivity and mood instability, potentially reducing suicide attempts, but their impact on cannabis consumption is less understood. The authors call for more rigorous pharmacological trials incorporating cannabis use variables to optimize combined treatment strategies.

Further elaborating on suicide prevention, the review addresses psychotherapeutic interventions such as cognitive behavioral therapy tailored for psychosis (CBTp) and motivational interviewing for substance use. These therapies may be most effective during identified opportunity windows, fostering insight, coping skills, and substance moderation. Expansion of these evidence-based therapies into community mental health services could bridge the gap between hospitalization and outpatient care, which often marks periods of heightened suicide vulnerability. Integrative care models that simultaneously target psychosis symptoms, cannabis use behaviors, and suicide risk stand to improve long-term outcomes dramatically.

Technological innovations also hold promise, as acknowledged in the review, with digital health tools offering novel channels to monitor risk indicators in real time. Mobile apps and wearable devices can capture behavioral changes, mood fluctuations, and substance use patterns, alerting clinicians to worsening states. Such real-time data streams could refine the identification of high-risk periods and opportunity windows, enabling timely, personalized interventions. The integration of artificial intelligence to analyze these complex datasets might transform psychiatric care from episodic to continuous and predictive.

Importantly, the review highlights the ethical and practical challenges inherent in studying and intervening during these vulnerable periods. Balancing patient autonomy with risk mitigation, maintaining confidentiality, and addressing the stigma attached to psychosis and cannabis use are ongoing hurdles. Sensitively designed clinical protocols that empower patients and families while ensuring safety are vital. The authors call for collaborative efforts across disciplines, including psychiatry, neurology, psychology, social work, and public health, to navigate these complexities successfully.

Ultimately, this comprehensive review signifies a paradigm shift in understanding first-episode psychosis, placing cannabis use and suicide risk within a temporal framework that identifies when risks peak and when interventions can pivot outcomes. This temporal mapping offers a beacon for clinicians and researchers aiming to reduce the substantial global burden of psychotic disorders and their devastating sequelae. As mental health fields move toward precision and integration, these insights arm stakeholders with knowledge to craft responsive, anticipatory care models attuned to dynamic risk trajectories.

Moving forward, further research should explore how cultural factors influence these risk and window periods, as well as investigate novel pharmacotherapies targeting the endocannabinoid system in psychosis contexts. Additionally, policy initiatives expanding early psychosis intervention programs, combined with substance use prevention, could operationalize the review’s findings at population levels. The potential to save lives and improve quality of life among young people facing the dual challenges of psychosis and cannabis use is immense—and timely scientific synthesis such as this lights the path forward.

As society increasingly grapples with mental health crises compounded by substance use and suicide, this narrative systematic review is a critical contribution. It urges a reorientation from fragmented treatment to holistic strategies that recognize and address the high-risk periods where timely interventions may pivot destinies. The synergistic interplay of first-episode psychosis, cannabis use, and suicide risk emerges not as accidental overlap but as a pattern of vulnerability with intervention potential. Harnessing this understanding could transform epidemiological burdens into opportunities for hope and recovery worldwide.

Subject of Research:
High-risk periods and opportunity windows in the intersection of first-episode psychosis, cannabis use, and suicide risk; implications for timely intervention and prevention.

Article Title:
High-Risk Periods and Opportunity Windows in First-Episode Psychosis, Cannabis Use, and Suicide Risk: A Narrative Systematic Review.

Article References:
Barresi, M., Martinotti, G., Maina, G. et al. High-Risk Periods and Opportunity Windows in First-Episode Psychosis, Cannabis Use, and Suicide Risk: A Narrative Systematic Review. Int J Ment Health Addiction (2025). https://doi.org/10.1007/s11469-025-01550-x

Image Credits:
AI Generated